Chronic beryllium disease: Don't miss the diagnosis

Journal of Respiratory Diseases

Volumn 24, Issue 8, 2003, Pages 357-363

  Glazer, Craig S ^a   Newman, Lee S ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHOTREXATE; PREDNISONE;

BERYLLIOSIS; COUGHING; DIAGNOSTIC ERROR; DYSPNEA; FATIGUE; FEVER; HUMAN; LUNG FUNCTION; PNEUMONIA; REVIEW; SARCOIDOSIS; SENSITIZATION; SKIN ULCER; SUBCUTANEOUS NODULE; WEIGHT REDUCTION; WHEEZING;

EID: 0042328113     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Newman LS, Metals that cause sarcoidosis. Semin Respir Infect. 1998;13:212-220.
2. Stonehouse A, Zenczak S. Properties, production processes, and applications. In: Rossman MD, Preuss O, Powers M, eds. Beryllium. Baltimore: Williams & Wilkins; 1991:27-55.
3. Kress J, Crispell K. Chemical pneumonitis in men working with fluorescent powders containing beryllium. Guthrie Clin Bull. 1944;13:61-95.
4. Chamberlin G, Jennings W, Lieben J. Chronic pulmonary disease associated with beryllium dust. The Pennsylvania Journal. 1957.
5. Stange AW, Furman FJ, Hilmas DE. Rocky Flats beryllium health surveillance. Environ Health Perspect. 1996;104(suppl 5):981-986.
6. Newman LS, Mroz MM Maier LA, et al. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med. 2001;43:231-237.
7. Kreiss K, Wasserman S, Mroz MM, Newman LS. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Med. 1993;35:267-274.
8. Kreiss K, Mroz MM, Zhen B, et al. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis. 1993;148(pt 1):985-991.
9. Kreiss K, Mroz MM, Zhen B, et al. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med. 1997;54:605-612.
10. 3. Am J Ind Med. 1996;30:16-25.
11. Henneberger PK, Cumro D, Deubner DD, et al. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health. 2001;74:167-176.
12. Maier LA. Genetic and exposure risks for chronic beryllium disease. Clin Chest Med. 2002; 23:827-839.
13. Newman LS, Lloyd J, Daniloff E. The natural history of beryllium sensitization and chronic beryllium disease. Environ Health. Perspect. 1996;104(suppl 5):937-943.
14. Mroz M, Martyny J, Hoover M. Exposure-response relationships for beryllium sensitization and disease. Am J Respir Crit Care Med. 1997; 155:A812.
15. Newman LS, Maier L. Beryllium. In: Sullivan J, Krieger G, eds. Clinical Environmental Health and Toxic Exposures. 2nd ed. Philadelphia. Lippincott, Williams & Wilkins; 2001:919-926.
16. Lundgren RA, Maier LA, Rose CS, et al. Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease. Chest. 2001;120;1702-1708.
17. Newman LS, Buschman DL, Newell JD Jr, Lynch DA. Beryllium disease: assessment with CT. Radiology. 1994;190:835-840.
18. Pappas GP, Newman LS. Early pulmonary physiologic abnormalities in beryllium disease. Am Rev Respir Dis. 1993;148:661-666.
19. Dudley H. The pathologic changes of chronic beryllium disease. AMA Arch Ind Health. 1959; 19:102-105.
20. Sawyer RT, Maier LA, Kittle LA, Newman LS. Chronic beryllium disease: a model interaction between innate and acquired immunity. Int Immunopharmacol. 2002;2:249-261.
21. Newman LS. Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect. 1996;104(suppl 5):953-956.
22. Mroz MM, Kreiss K, Lezotte DC, et al. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol. 1991;88:54-60.
23. Newman LS, Kreiss K, King TE Jr, et al. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis. 1989;139:1479-1486.
24. Newman LS. Occupational illness. N Engl J Med 1995;333:1128-1134.
25. Wang KP, Mehta AC, eds. Flexible Bronchoscopy. Cambridge, United Kingdom: Blackwell Science; 1995.
26. Roethe RA, Fuller PB, Byrd RB, Hafermann DR. Transbronchoscopic lung biopsy in sarcoidosis. Optimal number and sites for diagnosis. Chest. 1980;77:400-402.
27. Sprince NL, Kanarek DJ, Weber AL, et al. Reversible respiratory disease in beryllium workers. Am Rev Respir Dis. 1978;117:1011-1017.
28. Nishikawa S, Hirata T, Kitaichi M, Izumi T. Three years prospective study of Mantoux reactions in factory workers exposed to beryllium oxide. In: Jones Williams W, Davies B, eds. Proceedings Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. Cardiff, Wales: Alpha Omega Publishing; 1980: 722-727.
29. Stoeckle JD, Hardy HL, Weber AL. Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature. Am J Med. 1969;46:545-561.
30. DeNardi JM. Long-term experience with beryllium disease. AMA Arch Ind Health. 1959; 19:110-116.
31. Wright GW. Interpretation of results of ACTH and cortisone therapy in chronic beryllium poisoning. Arch Ind Hyg Occup Med. 1951;3:617-621.
32. Maier LA. Clinical approach to chronic beryllium disease and other nonpneumoconiotic interstitial lung diseases. J Thorac Imaging. 2002; 17:273-284.
33. Yoshida T, Shima S, Nagaoka K, et al. A study on the beryllium lymphocyte transformation test and the beryllium levels in working environment. Ind Health. 1997;35:374-379.
34. Israel H, Cooper D. Chronic beryllium disease due to low beryllium content alloys. Am Rev Respir Dis. 1964;89:100-102.
35. Balkissoon RC, Newman LS. Beryllium copper alloy (2%) causes chronic beryllium disease. J Occup Environ Med. 1999;41:304-308.